# Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

> **NCT01336296** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 61 (actual)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **DRUG:** mycophenolic acid

## Key facts

- **NCT ID:** NCT01336296
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336296, "Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01336296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*